Actively Recruiting
Pan-Facial Layering of Hyaluronic Acid Filler
Led by Erevna Innovations Inc. · Updated on 2025-09-22
30
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recent advancements in anatomical studies have enabled a more sophisticated approach to treating patients with facial aesthetic concerns with hyaluronic acid (HA) fillers. For instance, volumizing a specific area of concern may be warranted, but it is essential to understand how the underlying patient anatomy is continuing to laxity and hollowness. Varying manufacturing technology have offered a range of HA fillers with different physical and chemical properties adapted to different indications, each one tailored to provide a slightly different outcome based on the needs of the patient. Given these advances in the medical aesthetic field, investigators and clinicians are seeking to develop a new methodology for providing patients with a more tailored and personalized treatment approach. This methodology includes using a pan-facial, multilayering treatment technique that can be employed by injectors once experience is gained with standard techniques. The goal of this study is to assess the efficacy and safety of layering HA from the Restylane line of soft tissue products to create a more harmonious and complete aesthetics results.
CONDITIONS
Official Title
Pan-Facial Layering of Hyaluronic Acid Filler
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Able and willing to sign informed consent
- Willing and able to follow study procedures
- In good health based on medical history
- No uncontrolled systemic diseases
- No medical conditions that increase risk or interfere with hyaluronic acid treatment, including neuromuscular disorders, facial nerve palsy, or skin infections at treatment sites
- No marked facial dermatochalasis, deep scarring, excessively thick sebaceous skin, or severe photodamage
- No history of allergic reactions to study device components, including lidocaine
- No tattoos, jewelry, or clothing obstructing treatment areas that cannot be removed
- No planned surgery or overnight hospitalization during the study
- No prior facial surgeries including lifts
- No facial semi-permanent or permanent fillers, synthetic implants, or fat transplantation in last 2 years
- No energy-based facial treatments in last 6 months
- No soft tissue fillers in face within last 12 months
- Female participants of childbearing potential must have a negative pregnancy test before treatment
- Female participants of childbearing potential must use effective birth control from baseline through 30 days after last dose or study end
- Female participants not pregnant, breastfeeding, or planning pregnancy during study and 30 days after last dose
- No investigational product use within 30 days prior to study or enrollment in another clinical trial
- No porphyria
- No active diseases like inflammation, infection, tumors, or cold sores near treatment sites
- No bleeding disorders or use of blood-thinning medications
- Agree to avoid over-the-counter NSAIDs for at least two weeks before treatment
- No need for immunosuppressants
You will not qualify if you...
- Active COVID-19 infection within 14 days before baseline treatment
- History of cystic acne
- Planned or recent dental procedures including teeth cleaning within 2 weeks before or after any treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erevna Innovations Inc.
Montreal, Quebec, Canada, H3Z 1C3
Actively Recruiting
Research Team
L
Laura Raco
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here